Danielle A Hylton1, Jane Turner2, Yaron Shargall3, Christian Finley4, John Agzarian5, Kazuhiro Yasufuku6, Christine Fahim7, Waël C Hanna8. 1. Department of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4L8, Canada. Electronic address: hyltonda@mcmaster.ca. 2. Division of Respirology, Department of Medicine, McMaster University, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada. Electronic address: jane.turner@medportal.ca. 3. Division of Thoracic Surgery, Department of Surgery, McMaster University, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada. Electronic address: shargal@mcmaster.ca. 4. Division of Thoracic Surgery, Department of Surgery, McMaster University, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada. Electronic address: finleyc@mcmaster.ca. 5. Division of Thoracic Surgery, Department of Surgery, McMaster University, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada. Electronic address: agzarij@mcmaster.ca. 6. Division of Thoracic Surgery, Department of Surgery, University of Toronto, 200 Elizabeth Street, Toronto, Ontario, M5G 2C4, Canada. Electronic address: Kazuhiro.Yasufuku@uhn.ca. 7. Department of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4L8, Canada. Electronic address: fahimchristine@gmail.com. 8. Department of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4L8, Canada; Division of Thoracic Surgery, Department of Surgery, McMaster University, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada. Electronic address: hannaw@mcmaster.ca.
Abstract
OBJECTIVES: The primary objective of this study is to systematically review all pertinent literature related to the use of ultrasonographic features to predict malignancy in mediastinal lymph nodes seen during endobronchial ultrasound (EBUS) procedures. MATERIALS AND METHODS: Two independent reviewers completed the search and review (PubMed, EMBASE, Medline, and Cochrane databases) of the resulting titles and abstracts. Following full-text screening, thirteen articles met the inclusion criteria. Heterogeneity prevented any meta-analysis, instead a narrative review was completed. Results from each included article are categorized by the following ultrasonographic features: shape, echogenicity, margin status, central necrosis, short axis length, and central hilar structure. Diagnostic tools are also described in detail. RESULTS: Absence of a central hilar structure and heterogeneous echogenicity were often associated with malignancy; however, consensus was not achieved amongst the included articles. The remaining ultrasonographic features were not consistently associated with malignancy or benign disease status, suggesting a need for prospective analysis. Four diagnostic tools were also assessed. These tools demonstrate that a combination of ultrasonographic features may accurately predict lymph node malignancy rather than a single feature. CONCLUSION: Analysis of ultrasonographic features may prevent the need for repeat EBUS procedures when initial biopsy results are inconclusive. However, prospective external validation of these features is required to determine their true predictive capability. PROSPERO registration number: CRD42017068468.
OBJECTIVES: The primary objective of this study is to systematically review all pertinent literature related to the use of ultrasonographic features to predict malignancy in mediastinal lymph nodes seen during endobronchial ultrasound (EBUS) procedures. MATERIALS AND METHODS: Two independent reviewers completed the search and review (PubMed, EMBASE, Medline, and Cochrane databases) of the resulting titles and abstracts. Following full-text screening, thirteen articles met the inclusion criteria. Heterogeneity prevented any meta-analysis, instead a narrative review was completed. Results from each included article are categorized by the following ultrasonographic features: shape, echogenicity, margin status, central necrosis, short axis length, and central hilar structure. Diagnostic tools are also described in detail. RESULTS: Absence of a central hilar structure and heterogeneous echogenicity were often associated with malignancy; however, consensus was not achieved amongst the included articles. The remaining ultrasonographic features were not consistently associated with malignancy or benign disease status, suggesting a need for prospective analysis. Four diagnostic tools were also assessed. These tools demonstrate that a combination of ultrasonographic features may accurately predict lymph node malignancy rather than a single feature. CONCLUSION: Analysis of ultrasonographic features may prevent the need for repeat EBUS procedures when initial biopsy results are inconclusive. However, prospective external validation of these features is required to determine their true predictive capability. PROSPERO registration number: CRD42017068468.
Authors: Filiz Oezkan; Stephan Eisenmann; Kaid Darwiche; Asmae Gassa; David P Carbone; Robert E Merritt; Peter J Kneuertz Journal: J Clin Med Date: 2021-11-30 Impact factor: 4.241
Authors: Seung Hyun Yong; Sang Hoon Lee; Sang-Il Oh; Ji-Soo Keum; Kyung Nam Kim; Moo Suk Park; Yoon Soo Chang; Eun Young Kim Journal: Transl Lung Cancer Res Date: 2022-01
Authors: Roel L J Verhoeven; Fausto Leoncini; Jorik Slotman; Chris de Korte; Rocco Trisolini; Erik H F M van der Heijden Journal: Respiration Date: 2021-06-24 Impact factor: 3.580